S&P 500

5.346,99

-0,11%

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

BEAM

Beam Inc. (BEAM)

Beam Inc.

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:BEAM

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
12/12/2022	15h45	TipRanks	BMO Capital Sticks to Their Hold Rating for Beam Therapeutics (BEAM)	NYSE:BEAM	Beam Inc.
05/12/2022	15h40	TipRanks	Wall Street Analysts Are Neutral on Top Healthcare Picks	NYSE:BEAM	Beam Inc.
02/12/2022	16h02	TipRanks	U.S. FDA Removes Clinical Hold For BEAM Drug Candidate	NYSE:BEAM	Beam Inc.
09/11/2022	02h25	TipRanks	Barclays Reaffirms Their Hold Rating on Beam Therapeutics (BEAM)	NYSE:BEAM	Beam Inc.
11/05/2022	03h57	TipRanks	Beam Therapeutics (BEAM) Gets a Hold Rating from RBC Capital	NYSE:BEAM	Beam Inc.
11/05/2022	03h17	TipRanks	Barclays Keeps a Hold Rating on Beam Therapeutics (BEAM)	NYSE:BEAM	Beam Inc.
10/05/2022	14h10	TipRanks	Beam Therapeutics (BEAM) Receives a Hold from J.P. Morgan	NYSE:BEAM	Beam Inc.
02/03/2022	02h45	TipRanks	Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD) and Beam Therapeutics (BEAM)	NYSE:BEAM	Beam Inc.
02/03/2022	02h26	TipRanks	Barclays Reaffirms Their Hold Rating on Beam Therapeutics (BEAM)	NYSE:BEAM	Beam Inc.
14/01/2022	10h11	TipRanks	Wells Fargo Sticks to Their Buy Rating for Beam Therapeutics (BEAM)	NYSE:BEAM	Beam Inc.
30/12/2021	17h35	TipRanks	William Blair Keeps a Buy Rating on Beam Therapeutics (BEAM)	NYSE:BEAM	Beam Inc.
12/08/2021	14h33	TipRanks	Understanding Beam Therapeutics’ Risk Factors Post Q2	NYSE:BEAM	Beam Inc.
06/07/2021	13h42	TipRanks	Apellis’ Pipeline Creating Attractive Entry Point, Analyst Says	NYSE:BEAM	Beam Inc.
12/05/2014	23h08	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NYSE:BEAM	Beam Inc.
12/05/2014	18h13	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NYSE:BEAM	Beam Inc.
02/05/2014	22h34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:BEAM	Beam Inc.
02/05/2014	22h34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:BEAM	Beam Inc.
02/05/2014	22h32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:BEAM	Beam Inc.
02/05/2014	22h30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:BEAM	Beam Inc.
02/05/2014	22h29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:BEAM	Beam Inc.
02/05/2014	22h28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:BEAM	Beam Inc.
02/05/2014	14h31	Edgar (US Regulatory)	(25)	NYSE:BEAM	Beam Inc.
30/04/2014	23h30	Business Wire	Suntory Holdings Completes Acquisition of Beam Inc.	NYSE:BEAM	Beam Inc.
30/04/2014	23h23	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NYSE:BEAM	Beam Inc.
30/04/2014	23h22	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NYSE:BEAM	Beam Inc.
30/04/2014	23h21	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NYSE:BEAM	Beam Inc.
30/04/2014	23h21	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NYSE:BEAM	Beam Inc.
30/04/2014	23h21	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NYSE:BEAM	Beam Inc.
30/04/2014	23h20	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NYSE:BEAM	Beam Inc.
30/04/2014	23h20	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NYSE:BEAM	Beam Inc.